Table 2

Liver function tests in rats fed standard and high-fat, cholesterol-rich diets with and without camel milk treatment for 8 weeks
Control (n=10) CCM (n=20) Ch (n=20) Ch M (n=20) F value P value
AST (U/L) 45.99 ± 2.47 48.16 ± 3.08 § 57.41 ± 3.18 †‡ 50.91±4.18†‡§ 35.49
<0.001
ALT (U/L) 52.43 ± 2.69 54.76 ± 4.18 § 70.77 ± 4.19 †‡ 56.68±3.90†‡§ 79.84
<0.001
AP (U/L) 85.39 ± 6.44 83.79 ± 6.36 § 116.33 ± 6.79 †‡ 104.80 ±6.12†‡§ 105.86
<0.001
GAMA-GT (U/L) 43.47 ± 8.19 44.14 ± 6.67 § 50.12 ±5.45 †‡ 45.74 ±3.95 †§ 4.46
0.006
Total bilirubin (mg/dl) 1.45 ± 0.23 1.28 ± 0.19 § 2.07 ± 0.44 †‡ 1.23 ± 0.14 †§ 36.70
<0.001
Direct bilirubin (mg/dl) 0.43 ± 0.08 0.49 ± 0.11§ 0.82 ± 0.10 †‡ 0.46 ± 0.08 †§ 61.65
<0.001
Total proteins (mg/dl) 4.6 ± 0.19 6.25 ± 0.23 †‡ 4.17 ± 0.15 †‡ 5.05 ± 0.41 †‡§ 199.68
<0.001
Serum albumin (mg/dl) 3.45 ± 0.05 3.85 ± 0.40 †§ 3.15 ± 0.09 †‡ 3.57 ± 0.28 †‡§

23.31

<0.001

CCM; control + milk group, Ch; cholesterol group, ChM; cholesterol + milk group. Values are presented as the mean ± SD. Significant differences between all groups were identified by ANOVA test presented by F value. When significant (p value < 0.05), a post hoc LSD test was performed to compare the groups. † p < 0.05 versus control, ‡ p < 0.05 versus CCM, § p < 0.05 versus Ch, ¶ p < 0.05 versus ChM.

Korish and Arafah

Korish and Arafah BMC Complementary and Alternative Medicine 2013 13:264   doi:10.1186/1472-6882-13-264

Open Data